Live-Attenuated Intranasal RSV Vaccine in Infants and Toddlers
The RSVt vaccine demonstrated promising immunogenicity profiles at both LD and HD strengths among infants and toddlers, without identified safety concerns. (Funded by Sanofi; ClinicalTrials.gov number, NCT04491877).
Authors
- Olubukola T. Idoko (ORCID: https://orcid.org/0000-0002-8802-2946)
- Sanjay Gurunathan (ORCID: https://orcid.org/0009-0007-7241-6370)
- Sanie Sesay (ORCID: https://orcid.org/0000-0001-6233-7854)
- Sergio L. Vargas (ORCID: https://orcid.org/0000-0002-9299-6428)
- Peter L. Collins (ORCID: https://orcid.org/0000-0001-7543-7299)
- Iris De Bruijn
- Sophie Pallardy
- Peyman Banooni
- Ursula J. Buchholz (ORCID: https://orcid.org/0000-0002-2329-3198)
- Scott Gallichan
- Agustin Bueso (ORCID: https://orcid.org/0009-0008-3529-6813)
- Doris Maribel Rivera
- Haritha Adhikarla (ORCID: https://orcid.org/0000-0002-4217-2180)
- Mandeep Singh Dhingra (ORCID: https://orcid.org/0000-0002-2507-7165)
- Eric Gerchman
- Rapi Nteene
- Enrique Rivas
- S A Berger
- Michael W. Simon
- Camille Vercasson
- Monica Gasparotto
- Henderson Edward
- Stephane Janicot
Institutions
- University of Kentucky (US)
- National University of General San Martín (AR)
- Sanofi (France) (FR)
- Sanofi (Netherlands) (NL)
- Sanofi (Canada) (CA)
- Honeywell (France) (FR)
- Sanofi (United States) (US)
- Matrix Institute on Addictions (US)
- Paradigm Pharmaceuticals (United States) (US)
- Universidad Metropolitana de Honduras (HN)
- Sanofi (Argentina) (AR)
- National Institute of Allergy and Infectious Diseases (US)
- Honduras Foundation for Agricultural Research (HN)
- Sanofi (Mexico) (MX)
- Matrix Research (United States) (US)
- Beverly Hills Cardiology (US)
- University of Chile (CL)
Publication Details
- Journal
- NEJM Evidence
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1056/evidoa2500026
- Citations
- 3
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 4.06